The suppression of cell motility through the reduction of FAK activity and expression of cell adhesion proteins by hAMSCs secretome in MDA-MB-231 breast cancer cells

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

Article  PubMed  Google Scholar 

Zhang CL, Huang T, Wu BL, He WX, Liu D (2017) Stem cells in cancer therapy: opportunities and challenges. Oncotarget 8(43):75756–75766

Article  PubMed  PubMed Central  Google Scholar 

Sarukhan A, Zanotti L, Viola A (2015) Mesenchymal stem cells: myths and reality. Swiss Med Wkly 145:w14229

PubMed  Google Scholar 

Tran C, Damaser MS (2015) Stem cells as drug delivery methods: application of stem cell secretome for regeneration. AdvDrug Deliv Rev 82–83:1–11

Google Scholar 

Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, Ludlow JW, Stricker DM, Potiny S, Green P, Halvorsen YD, Cheatham B, Storms RW, Gimble JM (2007) Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and proinflammatory factors. J Cell Physiol 212(3):702–709

Article  CAS  PubMed  Google Scholar 

Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217:318–324

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarojini H, Estrada R, Lu H, Dekova S, Lee MJ, Gray RD, Wang E (2008) PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts. J Cell Bioche 104(5):1793–1802

Article  CAS  Google Scholar 

Schinkothe T, Bloch W, Schmidt A (2008) In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev 17:199–206

Article  CAS  PubMed  Google Scholar 

Liu CH, Hwang SM (2005) Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32:270–279

Article  CAS  PubMed  Google Scholar 

Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377:539–544

Article  CAS  PubMed  Google Scholar 

Parsons JT (2003) Focal adhesion kinase: the first ten years. J Cell Sci 116:1409–1416

Article  CAS  PubMed  Google Scholar 

Schlaepfer DD, Mitra SK, Ilic D (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692:77–102

Article  CAS  PubMed  Google Scholar 

Calalb MB, Polte RT, Hanks SK (1995) Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 15:954–963

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tremblay L, Hauck W, Aprikian AG, Begin LR, Chapde-laine A, Chevalier S (1996) Focal adhesion kinase (pp125) expression, activation and association with paxillin and p50 in human metastatic prostate carcinoma. Int J Cancer 68(2):164–171

Article  CAS  PubMed  Google Scholar 

Judson PL, He X, Cance WG, Van Le L (1999) Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 86(8):1551–1556

Article  CAS  PubMed  Google Scholar 

Lark AL, Livasy CA, Calvo B, Caskey L, Moore DT, Yang X, Cance WG (2003) Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res 9:215–222

CAS  PubMed  Google Scholar 

Owens LV, Xu L, Cravenetal RJ (1995) Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55(13):2752–2755

CAS  PubMed  Google Scholar 

Safari F, Murata-Kamiya N, Saito Y, Hatakeyama M (2011) Mammalian pragmin regulates Src family kinases via the glu-pro-ile-tyr-ala (EPIYA) motif that is exploited by bacterial effectors. Proc Natl Acad Sci USA 108:14938–14943

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tactacan CM, Phua YW, Liu L, Zhang L, Humphrey ES, Cowley M, Pinese M, Biankin AV, Daly RJ (2015) The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling. Mol Cancer 14:139

Article  PubMed  PubMed Central  Google Scholar 

Senda Y, Murata-Kamiya N, Hatakeyama M (2016) C-terminal src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal src kinase activation loop that promotes cell motility. Cancer Sci 107(7):972–980. https://doi.org/10.1111/cas.12962

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahmani Z, Safari F (2020) Evaluating the in vitro therapeutic effects of human amniotic mesenchymal stromal cells on MiaPaca2 pancreatic cancer cells using 2D and 3D cell culture model. Tissue Cell 23:101479

Google Scholar 

Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M (2006) Focal adhesion kinase is a substrate and downstream Effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol 26(1):261–276

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD (2000) FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2:249–256

Article  CAS  PubMed  Google Scholar 

Safari F, Shafiee Nejad N, Aghaei Nejad A (2022) The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 signaling. Med Oncol 39:28

Article  CAS  PubMed  Google Scholar 

Shakery T, Safari F (2023) Downregulation of Pinkbar/pAKT and MMP2/MMP9 expression in MDA-MB-231 breast Cancer cells as potential targets in Cancer Therapy by hAMSCs Secretome. Cells Tissues Organs 212(2):155–163

Article  CAS  PubMed  Google Scholar 

Biscardi JS, Belsches AP, Parsons SJ (1998) Characterization of human epidermal growth factor receptor and c-Src in human breast tumor cells. Mol Carcinogen 21:261–272

Article  CAS  Google Scholar 

Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ (2000) Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res 2:203–210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE (1992) Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-Src oncogene product. Cancer Res 52:4773–4778

CAS  PubMed  Google Scholar 

Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JG, Hennipman A, Rijksen G (1996) c-Src protein expression is increased in human breast cancer. An immunohisto-chemical and biochemical analysis. J Pathol 180:383–388

Article  CAS  PubMed  Google Scholar 

Toi M, Osaki A, Yamada H, Toge T (1991) Epidermal growth factor receptor expression as a prognostic indicator in breast cancer. Eur J Cancer 27:977–980

Article  CAS  PubMed  Google Scholar 

Thomas SM, Brugge JS (1997) Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513–609

Article  CAS  PubMed  Google Scholar 

Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, Li YH, Kang TB, Xu RH (2013) Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis 34:803–811

Article  CAS  PubMed  Google Scholar 

Chen DL, Wang ZQ, Ren C, Zeng ZL, Wang DS, Luo HY, Wang F, Qiu MZ, Bai L, Zhang DS, Wang FH, Li YH, Xu RH (2013) Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer. J Translational Medici ne 11:277

Article  Google Scholar 

Hegele A, Heidenreich A, Kropf J, von Knobloch R, Varga Z, Hofmann R, Olbert P (2004) Plasma levels of cellular fibronectin in patients with localized and metastatic renal cell carcinoma. Tumor Biol 25:111–116

Article  CAS  Google Scholar 

Saito N, Nishimura H, Kameoka S (2008) Clinical significance of fibronectin expression in colorectal cancer. Mol Med Rep 1:77–81

CAS  PubMed  Google Scholar 

Wang Y, Kuramitsu Y, Ueno T, Suzuki N, Yoshino S, Iizuka N, Zhang X, Akada J, Oka M, Nakamura K (2012) Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer. Oncol Rep 28:1845–1850

Article  CAS  PubMed  Google Scholar 

Kawakami K, Fujita Y, Kato T, Mizutani K, Kameyama K, Tsumoto H, Miura Y, Deguchi T, Ito M (2015) Integrin beta4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane - resis-tance. Int J Oncol 47:384–390

Article  CAS  PubMed 

留言 (0)

沒有登入
gif